Industrial Pharmacy Residency Program For the Term 2016-2017 Dr. Ping I. Lee, Coordinator Room 1100, Tel. 416-946-0606 [email protected] Industrial Pharmacy Residency Program • Description – One year residency program administered by the Leslie Dan Faculty of Pharmacy, in cooperation with Participating Pharmaceutical Companies (all companies in the GTA area; wide variety of programs) • Purpose – To educate the resident about different aspects of industrial pharmacy and to provide an opportunity to gain industrial experience in selected areas • Eligibility – Applicant must be a pharmacist or a student in the final year of an undergraduate program at a Faculty of Pharmacy with some previous pharmacy experience • More Details – On the webpage: http://pharmacy.utoronto.ca/residency-programs/industrial-pharmacy and in the posted Terms of Reference Industrial Pharmacy Residency Program • Types – Two types of residency – General Residency (not currently available) – Specialty Residency (all currently participating companies) • Specialty Residency – Focused activities in one or two particular departments; unique opportunity to develop specialty skills in chosen area of interest • Activities – Full daily active participation in the selected area of specialty residency with opportunities to attend seminars and conferences – Major Project chosen by the resident in discussion with the supervisor; general supervision of major project by the Core Committee (Company Supervisor and Faculty Liaison); at least two meetings of the Core Committee during the residency – Role of the Faculty Liaison is to serve as an advocate for the resident, and to assure that the goals of the residency are being met – A report of the Major Project needs to be completed by the resident and approved by the Core Committee in addition to completing all other work of the program within one year of commencing the program in order to receive the residency certificate Areas of Opportunities for the Residency • Actavis Specialty Pharmaceuticals Co.** - Specialty in Market Access • Apotex Inc.* - Specialty in Medical Affairs and Pharmacokinetics • Astellas Pharma Canada Inc. - Specialty in Drug Information and Medical Affairs • Biogen Idec - Specialty in Market Access • • • Eli Lilly Canada Inc. - Specialty in Pricing Reimbursement and Patient Access - Specialty in Medical Information - Specialty in Oncology Marketing Glaxo SmithKline Inc.** - Specialty in Medical Information and Drug Safety Hoffmann-LaRoche Ltd. - Specialty in Drug Information - Specialty in Medical Affairs • Sanofi Pasteur - Specialty in Medical Affairs * Not participating in 2016-2017 ** New for 2016-2017 IPRP for 2014-2015 • Current Residents – – – – – Natasa Radovic (MI, Astellas) Carla Maxemous (OPRA representative) (MAcc, Biogen Idec) Christopher Lenhu (PRPA, Eli Lilly) Maureen Younan (MA, Hoffmann-La Roche) Michael Zhang (OM, Eli Lilly) MA: Medical Affairs MAcc: Market Access MI: Medical Information OM: Oncology Marketing OPRA: Ontario Pharmacy Residents Association PRPA: Pricing, Reimbursement and Patient Access IPRP Application Statistics 2008 - 2015 Year of Program Canadian Universities* Foreign Universities* Total Applications Total Accepted U of T Other USA Other 2008-2009 6(5) 1(1) 2 10(2) 19 8 2009-2010 4(2) 0 2 10 16 2 2010-2011 5 4(3) 1 9 19 3 2011-2012 4 4(3) 1 10 19 3 2012-2013 12(4) 5 2 1 20 4 2013-2014 19(2) 5(1) 2(1) 4 30 4 2014-2015 14(3) 5(1) 3(2) 0 22 6 2015-2016 14(4) 2(2) 1 4 21 6 * Number accepted in ( ) Application for the 2016-2017 Term • Resident Stipend - $48,500 for the specialty residency starting in September 2016 • Application Package – – – – – Completed Application Form (incl. reasons for enrolling) Three Letters of Reference Original Pharmacy Transcript A list of companies intended to apply Send to the Faculty for assessment • Timing – Application steps must be completed during the period Sept. 1 – Oct. 1, 2015 What happens after you send in the application? • If meeting eligibility criteria, the application package will be forwarded to the companies selected by the applicant • Applicants may send a letter to the Company Supervisors in early October • Suitable applicants will be contacted by the Company Supervisor for an interview during October and November • After offering the residency position and accepted by the selected applicant, the Company Supervisor will notify the Coordinator • Normal start date: during the month of Sept. 2016 More Information Available from: Coordinator: Dr. Ping I. Lee Room 1100, Tel. 416-946-0606 [email protected] Executive Assistant: Diana Becevello Room 512, Tel. 416-978-2880 [email protected] and http://pharmacy.utoronto.ca/residency-programs/industrial-pharmacy Questions? Good luck with your application!
© Copyright 2020